Overview

Price chart · mood · technical indicators

WAT

Waters Corporationstock Healthcare

Diagnostics & Research

$379.779.66%Current Market Mood:Neutral

Market Mood

Price Range (1Y)

$275.05$414.15

Current: $379.77

Market Comparison

vs Healthcare Sector & Diagnostics & Research Industry

WAT

+9.66%

1Y Performance

Healthcare

Sector 1Y

Diagnostics & Research

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio47.26Forward 26.18

EPS (TTM)$7.87-3.1% YoY

Profit margin11.9%HEALTHCARE

Market cap$36.52BLarge cap

Wall Street coverage

$400.52median target· current $307.19 (+30.4%)22 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 26.18
PEG ratio: 1.68
P/B: 2.43
P/S (TTM): 9.69
EV/EBITDA: 42.64

Profitability & growth

ROE (TTM): 5.2%
Operating margin: 2.8%
Revenue growth YoY: 91.4%
Dividend yield: —
Beta: 1.14

Last earnings

May 5, 2026 · Estimate $2.31 · Reported $2.70

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Waters Corporation

Company profile

Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.

Classification

Sector: Healthcare
Industry: Diagnostics & Research
Exchange: NYSE
Country: USA
Currency: USD

Company profile

HQ: 34 MAPLE STREET, MILFORD, MA
Fiscal year end: December
Latest quarter: Mar 31, 2026

Market cap$36.52B

Shares outstanding$98.2M

52W high$414.15

52W low$275.05

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer

Overview

WAT

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Waters Corp. stock outperforms competitors on strong trading day

Waters (WAT) Gains FDA Clearance for Automated Blood Culture Sys

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

FDA-cleared blood culture system flags sepsis infections 3 hours faster

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders

Waters Corp. stock outperforms competitors despite losses on the day

Wolfe Research initiates Waters stock with Outperform rating By Investing.com

Waters Corp. stock underperforms Monday when compared to competitors

Wolfe Research initiates Waters stock with Outperform rating By Investing.com

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Wolfe Research initiates Waters stock with Outperform rating By Investing.com

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks

Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research – Company Announcement - FT.com

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks

Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

Is It Too Late To Consider Agilent Technologies (A) After Its Recent Share Price Surge

About Waters Corporation

Classification

Company profile

WAT

Market Comparison

WAT Market Analysis

Overview

WAT

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Waters Corp. stock outperforms competitors on strong trading day

Waters (WAT) Gains FDA Clearance for Automated Blood Culture Sys

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

FDA-cleared blood culture system flags sepsis infections 3 hours faster

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders

Waters Corp. stock outperforms competitors despite losses on the day

Wolfe Research initiates Waters stock with Outperform rating By Investing.com

Waters Corp. stock underperforms Monday when compared to competitors

Wolfe Research initiates Waters stock with Outperform rating By Investing.com

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Wolfe Research initiates Waters stock with Outperform rating By Investing.com

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks

Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research – Company Announcement - FT.com

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks

Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

Is It Too Late To Consider Agilent Technologies (A) After Its Recent Share Price Surge

About Waters Corporation

Classification

Company profile

WAT

Market Comparison